Insurance coverage and cost Verify cost and insurance coverage for tirzepatide with your current health insurance plan or private insurance before making a switch
For researchers tracking this space, the key trials to watch in 2026 include the remaining TRIUMPH program readouts for retatrutide, the GLORY-OSA trial for mazdutide in obstructive sleep apnea, and the first Phase 1 data from several quadruple-agonist programs entering clinical development
Holman RR, Bethel MA, Chan JC, Chiasson JL, Doran Z, Ge J, Gerstein H, Huo Y, McMurray JJ, Ryden L, Liyanage W, Schrder S, Tendera M, Theodorakis MJ, Tuomilehto J, Yang W, Hu D, Pan C, ACE Study Group
Costco Wegovy and Ozempic self-injectable pens: $499 a month at out-of-pocket pricing
Retatrutide (LY-3437943) is a synthetic 39-amino-acid peptide developed as a triple agonist of the GLP-1, GIP and glucagon receptors
Mechanism of Action 2,3 Glucagon-like peptide-1 (GLP-1) is a hormone produced and secreted in intestinal cells and in the brainstem upon food consumption